MedTrace Logo

Age-related Variability of the Efficacy and Tolerability of Alternative Pituitary Suppression Regimens in ART

NCT01107470 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2012-03-26

No results posted yet for this study

Summary

Age-related variability of the efficacy and tolerability of alternative pituitary suppression regimens in follicular stimulation for assisted reproduction purposes. A randomised, prospective, multi-centre clinical trial

Conditions

Interventions

DRUG

hFSH（Fostimon）

After down-regulation (short protocol), all patients will be stimulated with hFSH (human-derived FSH).

DRUG

hFSH（Fostimon）

After down-regulation (short protocol), all patients will be stimulated with hFSH (human-derived FSH).

DRUG

hFSH（Fostimon）

After down-regulation (long protocol), all patients will be stimulated with hFSH (human-derived FSH).

DRUG

hFSH（Fostimon）

After down-regulation (long protocol), all patients will be stimulated with hFSH (human-derived FSH).

Sponsors & Collaborators

  • The First Affiliated Hospital of Zhengzhou University

    collaborator OTHER

  • IBSA Institut Biochimique SA

    collaborator INDUSTRY

  • The Second Hospital of Hebei Medical University

    collaborator OTHER

  • Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

    collaborator OTHER

  • Shandong University

    lead OTHER

Principal Investigators

  • Zijiang Chen, Professor · Director of Shandong University reproductive medicine study center

Eligibility

Min Age
18 Years
Max Age
42 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2013-04-30
Completion
2013-04-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01107470 on ClinicalTrials.gov